Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.

The chemokine Stromal cell-derived factor 1α (SDF1α, CXCL12) is currently under investigation as a biomarker for various cardiac diseases. The correct interpretation of SDF1α levels is complicated by the occurrence of truncated forms that possess an altered biological activity.We studied the immunor...

Full description

Bibliographic Details
Main Authors: Lesley Baerts, Yannick Waumans, Inger Brandt, Wolfgang Jungraithmayr, Pieter Van der Veken, Marc Vanderheyden, Ingrid De Meester
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4636157?pdf=render
_version_ 1828370252305530880
author Lesley Baerts
Yannick Waumans
Inger Brandt
Wolfgang Jungraithmayr
Pieter Van der Veken
Marc Vanderheyden
Ingrid De Meester
author_facet Lesley Baerts
Yannick Waumans
Inger Brandt
Wolfgang Jungraithmayr
Pieter Van der Veken
Marc Vanderheyden
Ingrid De Meester
author_sort Lesley Baerts
collection DOAJ
description The chemokine Stromal cell-derived factor 1α (SDF1α, CXCL12) is currently under investigation as a biomarker for various cardiac diseases. The correct interpretation of SDF1α levels is complicated by the occurrence of truncated forms that possess an altered biological activity.We studied the immunoreactivities of SDF1α forms and evaluated the effect of adding a DPP4 inhibitor in sampling tubes on measured SDF1α levels. Using optimized sampling, we measured DPP4 activity and SDF1α levels in patients with varying degrees of heart failure.The immunoreactivities of SDF1α and its degradation products were determined with three immunoassays. A one hour incubation of SDF1α with DPP4 at 37°C resulted in 2/3 loss of immunoreactivity in each of the assays. Incubation with serum gave a similar result. Using appropriate sampling, SDF1α levels were found to be significantly higher in those heart failure patients with a severe loss of left ventricular function. DPP4 activity in serum was not altered in the heart failure population. However, the DPP4 activity was found to be significantly decreased in patients with high SDF1α levels.We propose that all samples for SDF1α analysis should be collected in the presence of at least a DPP4 inhibitor. In doing so, we found higher SDF1α levels in subgroups of patients with heart failure. Our work supports the need for further research on the clinical relevance of SDF1α levels in cardiac disease.
first_indexed 2024-04-14T06:36:34Z
format Article
id doaj.art-7cc93140e68341adbabe05740d8da14a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T06:36:34Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7cc93140e68341adbabe05740d8da14a2022-12-22T02:07:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014140810.1371/journal.pone.0141408Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.Lesley BaertsYannick WaumansInger BrandtWolfgang JungraithmayrPieter Van der VekenMarc VanderheydenIngrid De MeesterThe chemokine Stromal cell-derived factor 1α (SDF1α, CXCL12) is currently under investigation as a biomarker for various cardiac diseases. The correct interpretation of SDF1α levels is complicated by the occurrence of truncated forms that possess an altered biological activity.We studied the immunoreactivities of SDF1α forms and evaluated the effect of adding a DPP4 inhibitor in sampling tubes on measured SDF1α levels. Using optimized sampling, we measured DPP4 activity and SDF1α levels in patients with varying degrees of heart failure.The immunoreactivities of SDF1α and its degradation products were determined with three immunoassays. A one hour incubation of SDF1α with DPP4 at 37°C resulted in 2/3 loss of immunoreactivity in each of the assays. Incubation with serum gave a similar result. Using appropriate sampling, SDF1α levels were found to be significantly higher in those heart failure patients with a severe loss of left ventricular function. DPP4 activity in serum was not altered in the heart failure population. However, the DPP4 activity was found to be significantly decreased in patients with high SDF1α levels.We propose that all samples for SDF1α analysis should be collected in the presence of at least a DPP4 inhibitor. In doing so, we found higher SDF1α levels in subgroups of patients with heart failure. Our work supports the need for further research on the clinical relevance of SDF1α levels in cardiac disease.http://europepmc.org/articles/PMC4636157?pdf=render
spellingShingle Lesley Baerts
Yannick Waumans
Inger Brandt
Wolfgang Jungraithmayr
Pieter Van der Veken
Marc Vanderheyden
Ingrid De Meester
Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.
PLoS ONE
title Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.
title_full Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.
title_fullStr Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.
title_full_unstemmed Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.
title_short Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.
title_sort circulating stromal cell derived factor 1α levels in heart failure a matter of proper sampling
url http://europepmc.org/articles/PMC4636157?pdf=render
work_keys_str_mv AT lesleybaerts circulatingstromalcellderivedfactor1alevelsinheartfailureamatterofpropersampling
AT yannickwaumans circulatingstromalcellderivedfactor1alevelsinheartfailureamatterofpropersampling
AT ingerbrandt circulatingstromalcellderivedfactor1alevelsinheartfailureamatterofpropersampling
AT wolfgangjungraithmayr circulatingstromalcellderivedfactor1alevelsinheartfailureamatterofpropersampling
AT pietervanderveken circulatingstromalcellderivedfactor1alevelsinheartfailureamatterofpropersampling
AT marcvanderheyden circulatingstromalcellderivedfactor1alevelsinheartfailureamatterofpropersampling
AT ingriddemeester circulatingstromalcellderivedfactor1alevelsinheartfailureamatterofpropersampling